Remote sleep therapy for children with oppositional defiant disorder and insomnia
Tests remote sleep therapy for children with oppositional defiant disorder.
Key facts
- Who runs it
- University of South Florida
- Where
- Tampa, United StatesSee the site
- Trial code
- Registry title
- SLEEP-COPE: Sleep Intervention for Oppositional Children
- Status
- Recruiting
- People taking part
- 25 people, planned
- Started
- 1 Apr 2024
- Planned end
- 1 Oct 2025
- Type of study
- Interventional
- Treatments tested
- SLEEP: COPE
- Record updated
- 28 March 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children aged 8-12 with Oppositional Defiant Disorder (ODD) and long-lasting sleep problems (insomnia), together with a parent. It tests a short sleep therapy program done by video call.
- Age
- 8 to 12 years (child)
- Sex
- All
- Disease stage
- The child already has an ODD diagnosis. The child has had trouble falling asleep, staying asleep, or waking too early for 3+ months. The sleep problems affect mood, thinking, social life or school during the day.
- Earlier treatment
- The child cannot be getting other non-drug sleep treatment, such as CBT, outside this trial. Medicines that change sleep are not allowed, except stimulants, sleep medicines and melatonin.
- Biomarker or test result
- Sleep diaries and a wrist activity monitor (actigraphy) must show more than 30 mins of trouble falling asleep, waking at night, or waking early on 6+ nights.
Main reasons for not taking part
- Child or parent does not speak English well
- Child has other untreated health problems, such as other sleep disorders, epilepsy, psychotic disorders or suicidal thoughts
- Child or parent is in another randomized research study
- Family does not accept being assigned to a group by chance
- Child cannot wear a Holter heart monitor or activity monitor
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Child ages 8-12 with ODD (prior diagnosis) and insomnia
- Child and parent English proficiency; Insomnia:
- complaints of difficulties falling asleep, staying asleep, or early morning awakening by child report or parent observation for 3+ mos
- daytime dysfunction (mood, cognitive, social, academic) due to insomnia
- baseline diaries and actigraphy indicate >30 mins. of sleep onset latency, wake after sleep onset, or early morning awakening (time between last awakening and out of bed time) on 6+ nights
Who cannot take part
- Child psychotropic or other medications that alter sleep with the exceptions of stimulants, sleep medications, and/or melatonin
- Parent unable to complete forms or implement treatment procedures due to cognitive impairment
- Child untreated medical comorbidity, including other sleep disorders (e.g., apnea, epilepsy, psychotic disorders, suicidal ideation/intent, [frequent] parasomnias)
- Other conditions adversely affecting trial participation
- Parent unable to provide informed consent or child unable to provide assent
- Family unwilling to accept random assignment
- Child/parent participation in another randomized research project
- Child participation in non-pharmacological treatment (including CBT) for sleep outside current trial
- Parent report of inability to undergo Holter Monitoring or actigraphy (e.g., extreme sensitivity, behavioral outbursts)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 8 and 12 years old?
Where in United States
- University of South FloridaTampa, United StatesContact: Melanie Stearns, PhDTaking people
About the trial
What the trial wants to find out
Children with Oppositional Defiant Disorder (ODD) are at risk for insomnia, arousal dysfunction, mood problems, and noncompliance. Cognitive behavioral treatment for insomnia (CBT-I) holds promise for improving insomnia and related concerns. Telehealth delivery will reduce the burden of in-person sessions, particularly in areas where there is low mental healthcare access. Telehealth CBT-I is efficacious in adults and children but has not been tested in children with ODD. The proposed trial is the next logical step - development and iterative testing of SLEEP-COPE, a brief dyadic telehealth CBT-I for children with ODD and their parents.
The group in the trial
- SLEEP: COPETreatment being tested
Content includes both standard CBT-I techniques \[sleep hygiene, stimulus control, sleep restriction, cognitive therapy\] as well as those targeting children with ODD and their parents. Active child participation is a goal but may be limited due to age/abilities. Parents will work with children to implement behavioral strategies.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- SLEEP-COPE: Sleep Enhancement and Effective Parenting for Children with Oppositional and Problematic Expressions
- Plain-language title
- Remote sleep therapy for children with oppositional defiant disorder and insomniaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT06350292, who can take part
- Record updated
- 28 March 2025